We value our relationships and strive to be your trusted partner. As the primary preclinical partner for the development of approved ophthalmic therapies, and clinical testing approval for many others, we know our approach works.
It starts with understanding your product, its development needs and your pressures. By committing to apply industry-leading ophthalmic expertise from our 70+ member team efficiently, strategically, at high quality, we endeavor to achieve your development goals, earning your trust along the way.
As a cofounder and Chief Science Officer for OSOD, I am honored to work with and introduce our team of vision scientists. Our team includes academic investigators, veterinary and physician clinicians, and pharmaceutical industry scientists and regulatory experts. With this wide breadth of expertise, we provide services that span the entire therapy development pathway from discovery to clinical testing.
My 30+ year career at the University of Wisconsin as a retinal specialist and in the Department of Ophthalmology and Visual Sciences has allowed me to keep abreast of the truly remarkable advances in ophthalmology which have occurred over this time. Participating in the development of the discoveries OSOD has contributed to that are now providing significant improvements in the lives of patients I care for is one the most rewarding aspects of my career. I know I speak for our entire team to say that it will be a privilege to partner with you to continue to advance your new and innovative ophthalmic therapies.